Fig. 6From: Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancerCorrelation of the methylation status of the HIN-1 promoter in tumor and tumor-adjacent tissuesBack to article page